Call Toll Free 1800-425-8282 Initial Public Offer - Note Eris Lifesciences Ltd Eris Lifesciences Ltd Issue Highlights: Issuer: Eris Lifesciences Ltd Issue Type: 100% Book Built Issue IPO Issue Open: Friday June 16, 2017 Issue Close: Tuesday, June 20, 2017 Issue Size (Rs)*: 1,740.30 Crores Face Value: Rs.1 per Equity Share Price Band: Rs. 600 – Rs. 603 per Equity Share Minimum Order Quantity Retail: 24 Shares and in multiples thereafter Maximum Bid amount for Retail: Rs. 2 Lakhs Employee Reservation: 1,50,000 shares Employee Discount: Rs. 60/- per share Listing: NSE & BSE Issue Size and Investor Category Allocation Total Issue Size: 2,88,75,000 Equity Shares* QIB: 75% of the issue size (2,15,43,750 Shares*) HNI: 15% of the issue size (43,08,750 Shares*) Retail Individual Bidders: 10% of the issue size (28,72,500 Shares*) (* upper price band) Book Running Lead Managers: Axis Capital, Citigroup Global, Credit Suisse Securities Registrar: Link Intime India Pvt Ltd Key Business Strategies: Consolidate our position in therapeutic areas in which we have significant presence Target and enhance our presence in large and high- growth therapeutic areas Explore in-licensing and co-development opportunities to leverage our sales, marketing and distribution and manufacturing infrastructure Target future patent expiries in India Enhance our product line and expand our capabilities through strategic acquisitions Key Strengths: Focus on branded prescription based pharmaceutical products catering to lifestyle related disorders One of the fastest growing companies in certain high growth therapeutic areas with a portfolio of complementary products Portfolio of high volume and leading brands Focus on metro cities and class 1 towns in India which have higher incidence of lifestyle disorders and Concentration of specialists and super specialists Multi-faceted product selection and engagement model leading to growth in prescription for our products Strong sales, marketing and distribution capabilities Objects of the Issue: 1. The objects of the Offer are to achieve the benefits of listing the Equity Shares on the Stock Exchanges and for the sale of up to 28,875,000 Equity Shares by the Selling Shareholders 2. General Corporate Purpose. Public issue of 2,88,75,000 equity shares of Rs. 10/- each (“equity shares”) of Eris Lifesciences Ltd(Company or Issuer). About the Issuer: Eris Lifesciences Limited (“Eris”) was incorporated on January 25, 2007. Eris is developing, manufacturing and commercializing branded pharmaceutical products in select Therapeutic areas within the Chronic and Acute Categories of the Indian Pharmaceutical Market (“IPM”), such as: Cardiovascular; Anti-Diabetics; Vitamins; Gastroenterology; and Anti-Infectives. It is the fastest growing company, in the Chronic category, among the top 25 companies in terms of revenues, with revenue growth at CAGR of 28.9%, between Fiscals 2013 and 2017. The Chronic category of the IPM contributed 65.6% of their revenues and Acute Category of the IPM contributed 34.4% in fiscal 2017. The product portfolio is primarily focused on therapeutic areas which require the intervention of specialists and super specialists such as cardiologists, diabetologists, endocrinologists and gastroenterologist For Fiscals 2016, 2015 and 2014, our net revenue from operations was Rs. 5,970.21 million, Rs. 5,455.58 million and Rs. 5,088.22 million, respectively. Net revenue from operations grew at a CAGR of 21.50% between Fiscals 2012 and 2016. Revenue from Operations (Rs. Millions) Net Profit After Tax (Rs. Millions) 4170.19 5204.62 5479.86 6054.83 0 2000 4000 6000 8000 FY 13 FY 14 FY 15 FY 16 657.96 655.27 833.25 1379.71 0 500 1000 1500 FY 13 FY 14 FY 15 FY 16
3
Embed
Eris Lifesciences Ltd - IPO - karvyvalue.com · 2014 March 31, 2013 March 31, 2012 I. EQUITY AND LIABILITIES : (1) Shareholders' Funds (a) Share capital 137.50 1.38 1.38 1.38 1.38
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Call Toll Free 1800-425-8282
Initial Public Offer - Note
Eris Lifesciences Ltd
Eris Lifesciences Ltd
Issue Highlights:
Issuer: Eris Lifesciences Ltd
Issue Type: 100% Book Built Issue IPO
Issue Open: Friday June 16, 2017
Issue Close: Tuesday, June 20, 2017
Issue Size (Rs)*: 1,740.30 Crores
Face Value: Rs.1 per Equity Share
Price Band: Rs. 600 – Rs. 603 per Equity Share
Minimum Order Quantity Retail: 24 Shares and in
multiples thereafter
Maximum Bid amount for Retail: Rs. 2 Lakhs
Employee Reservation: 1,50,000 shares
Employee Discount: Rs. 60/- per share
Listing: NSE & BSE
Issue Size and Investor Category Allocation
Total Issue Size: 2,88,75,000 Equity Shares*
QIB: 75% of the issue size (2,15,43,750 Shares*)
HNI: 15% of the issue size (43,08,750 Shares*)
Retail Individual Bidders: 10% of the issue size (28,72,500